Early Diagnosis of Alzheimer’s: A Personal Story
Losing a job after three decades was the first real indication that something was amiss, writes Brent Beasley, a physician, in the Wall Street Journal. At that time, nobody recognized it as early signs of Alzheimer’s disease. He recalls that two years ago, his supervisor unexpectedly called him into her office and let him go. Struggling to remember instructions and having trouble with technology he had previously mastered, she likely assumed he had a substance abuse issue. Ultimately, he discovered he was dealing with undiagnosed Alzheimer’s at just 57 years old. After nearly a year of tests, including a blood biomarker and spinal tap, his diagnosis was finally confirmed.
Beasley believes that catching the disease early transformed his experience. Early detection allowed him to access lifestyle changes and a new anti-amyloid medication, which he claims restored his clarity. He even told his wife after a church service, “I’m back.” Now, more than two years post-diagnosis, he asserts he is “living a joyful, purposeful life.” He points out that, despite his medical background, navigating the healthcare system took considerable time. He likens early Alzheimer’s diagnosis to catching stage one cancer rather than stage four: if found early, it opens the door to lifestyle or medical interventions that can slow progression.
Using his situation as a platform, Beasley advocates for making early detection of Alzheimer’s a national priority. With as many as 40% of dementia cases potentially preventable or manageable with timely action, he argues that the current system, which focuses on late-stage care, falls short, particularly for those lacking medical connections, resources, or access to specialists. “If it was challenging for me, a physician with a supportive spouse, to get a timely diagnosis, think about how difficult it must be for others,” he reflects.
He emphasizes the need for greater accessibility to blood tests for earlier diagnoses, insurance coverage for FDA-approved medications, improved primary care detection, and enhanced support for caregivers. According to him, “An Alzheimer’s diagnosis doesn’t have to be the devastating blow it once was.” With advancements in science, there’s potential for patients like him to remain cognitively engaged and healthy. However, he warns that without a collective national push for early diagnosis and treatment, these medical breakthroughs may never reach those who need them the most.





